Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV002214427 | SCV002497504 | pathogenic | not provided | 2022-02-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502031 | SCV002807879 | likely pathogenic | Primary ciliary dyskinesia 7 | 2022-01-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003653584 | SCV004513861 | pathogenic | Primary ciliary dyskinesia | 2024-09-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg1264Ilefs*10) in the DNAH11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNAH11 are known to be pathogenic (PMID: 18022865, 20513915, 22184204). This variant is present in population databases (rs749926976, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with DNAH11-related conditions. For these reasons, this variant has been classified as Pathogenic. |